INVITE (ATHN) | BEST IDEA UPDATE CALL

INVITE (ATHN) | BEST IDEA UPDATE CALL - 2015 07 14 Best Idea Update

athenahealth (athn) best idea update call 

We added athenahealth (ATHN) to the Hedgeye Best Idea List as a Long in August 2014.  Since then, we have heard push back and praise from investors on both sides of the debate.  We've continuously reevaluated our thesis and added depth to our research along the way, and at each turn found ourselves arriving at the same conclusion with more confidence than before.  We remain long ATHN and believe the stock will reclaim $200 as our long thesis plays out.

 

CLICK HERE TO WATCH VIDEO SUMMARY

 

In the presentation, we will review much of the incremental work completed over the last year, challenge the bear case using market share data from SK&A, and evaluate the company's ability to succeed in the inpatient space, which we see as much improved from where they were a year ago.  We will also unveil at least one new tracker (with others in development) that will give us visibility into share gain/losses by other vendors on weekly basis and review the results of our EHR/RCM pricing survey.

 

This call will be held on Thursday, July 23rd at 11:00am ET.

 

Please contact  for further information.  An invite with dial-in instructions will be sent to subscribers ahead of the conference call.

 

INVITE (ATHN) | BEST IDEA UPDATE CALL - 2015 07 15 Practice Management Share

presentation outline

  • Company and financial snapshot
  • Business model overview
  • Regulatory backdrop
    • Meaningful Use
    • PQRS / ACOs / FQHCs
    • Fee for Value
  • Practice Management & EHR Market Share Analysis 
    • Epic, Cerner, eClinicalWorks, Allscripts and more
    • Independent vs. Health System
    • Share by specialty and size
    • How big of a threat are Epic and Cerner?
  • Inpatient Opportunity
    • Market share analysis
    • Pricing and modelling adoption
  • Key Drivers
    • ATHN Tracker Update… Q2 Doc Add Preview
    • NEW tracker introduction
    • Results of RCM/EHR Pricing Survey
  • Field Notes
    • Former CPSI Sales Rep
    • Current Healthland Sales Rep
    • CEO of RazorInsights Hospital
    • Former Sales Manager eClinicalWorks
  • Valuation and sentiment
  • Risks and timing
     

Please call or e-mail with any questions.

 

Thomas Tobin
Managing Director 

@HedgeyeHC

 

Andrew Freedman

Analyst

@HedgeyeHIT 

 

 


Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more